Loading...
PACE4-Based Molecular Targeting of Prostate Cancer Using an Engineered (64)Cu-Radiolabeled Peptide Inhibitor()()
The potential of PACE4 as a pharmacological target in prostate cancer has been demonstrated as this proprotein convertase is strongly overexpressed in human prostate cancer tissues and its inhibition, using molecular or pharmacological approaches, results in reduced cell proliferation and tumor prog...
Na minha lista:
| Udgivet i: | Neoplasia |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Neoplasia Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4235008/ https://ncbi.nlm.nih.gov/pubmed/25220591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.07.010 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|